Home > Riviste > Minerva Biotechnology and Biomolecular Research > Fascicoli precedenti > Minerva Biotechnology and Biomolecular Research 2021 June;33(2) > Minerva Biotechnology and Biomolecular Research 2021 June;33(2):51-2

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

EDITORIAL  BIOTECHNOLOGICAL AND PHARMACOLOGICAL DEVELOPMENTS IN THE MODIFICATION OF CHRONIC INFLAMMATION-INDUCED DISEASES Free accessfree

Minerva Biotechnology and Biomolecular Research 2021 June;33(2):51-2

DOI: 10.23736/S2724-542X.21.02803-0

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Hot topics in chronic inflammation-induced diseases at the time of COVID-19

Tetyana FALALYEYEVA 1 , Rinaldo PELLICANO 2

1 Educational and Scientific Center Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; 2 Unit of Gastroenterology, Molinette Hospital, Turin, Italy



inizio pagina